Brevan Howard Capital Management’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.8M Buy
+21,050
New +$5.95M 0.04% 291
2025
Q4
Sell
-2,453
Closed -$707K 1865
2025
Q3
$707K Sell
2,453
-66,920
-96% -$19.8M ﹤0.01% 1094
2025
Q2
$22.9M Buy
69,373
+46,934
+209% +$15.1M 0.13% 78
2025
Q1
$7.38M Sell
22,439
-11,146
-33% -$3.36M 0.07% 83
2024
Q4
$9.27M Buy
33,585
+14,630
+77% +$4.66M 0.06% 76
2024
Q3
$6.57M Sell
18,955
-11,903
-39% -$4.1M 0.05% 97
2024
Q2
$10.2M Buy
+30,858
New +$10.6M 0.09% 49
2024
Q1
Sell
-1,154
Closed -$346K 1043
2023
Q4
$346K Buy
+1,154
New +$337K ﹤0.01% 656

Other funds holding CI

Brevan Howard Capital Management's CI Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Cigna (CI) in Q2 2026: 21,050 shares worth $5.8M. The stake represents 0.04% of the portfolio and ranks #291 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in CI as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in CI in Q4 2023 and has held it in 8 quarters since. The position peaked at $22.9M in Q2 2025. 1,700 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Brevan Howard Capital Management held 21,050 shares of Cigna worth $5.8M as of Q2 2026.
  • Cigna was a new Brevan Howard Capital Management position in Q2 2026.
  • Cigna made up 0.04% of Brevan Howard Capital Management's portfolio in Q2 2026, its #291 holding.
  • Brevan Howard Capital Management first reported a position in Cigna in Q4 2023 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's Cigna position peaked at $22.9M in Q2 2025.
  • 1,700 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.